Something wrong? Let us know
Checked
Federal dataHealth
Omalizumab
Published by U.S. Food and Drug Administration · Updated 03/17/2025 · Yearly
- Last updated
- 03/17/2025
- First published 09/16/2016
- Update frequency
- Yearly
- Formats
- Web only
- Coverage
- Nationwide
- Federal data
About this dataset
Xolair (omalizumab) is a prescription medication made by Genentech, Inc., used to treat allergic asthma and chronic hives by blocking IgE antibodies that trigger allergic reactions. It's administered as a subcutaneous injection in vials or prefilled syringes with strengths like 75 mg, 150 mg, or 300 mg. This information was generated using AI and is provided for informational and research purposes only.
Files and access
Links open the official government source
- Omalizumabaccessdata.fda.govWeb page
Links open outside websites we do not control.
Frequently asked questions
- Who publishes Omalizumab?
- U.S. Food and Drug Administration, part of U.S. Department of Health & Human Services, publishes this dataset on Data.gov.
- How often is it updated?
- The publisher lists the update frequency as yearly. The last update was on 03/17/2025.
- How do I download it?
- Use the official source link above to view or request the data.
Similar data from other publishers
- OmalizumabState of VirginiaXolair (omalizumab) is a prescription medication made by Genentech, Inc., used to treat allergic asthma and chronic hives by blocking IgE antibodies that trigger allergic reactions. It's administered as a subcutaneous injection in vials or prefilled syringes wUpdated 03/25/2026
- VedolizumabState of VirginiaEntyvio (vedolizumab) is a prescription biologic medication that blocks certain immune cells from entering the gut, reducing inflammation. It's used to treat moderate to severe ulcerative colitis or Crohn's disease in adults who haven't responded well to otherUpdated 09/29/2026
- InebilizumabState of VirginiaUPLIZNA (inebilizumab) is a prescription monoclonal antibody that targets CD19 on immune cells. It's administered intravenously for certain autoimmune conditions. Manufactured by Viela Bio and Horizon Therapeutics, it's available as a 10 mg/mL solution in singUpdated 09/29/2026
- AtezolizumabState of VirginiaTecentriq (atezolizumab) is a prescription monoclonal antibody made by Genentech, Inc., given intravenously to treat certain cancers. It works by blocking PD-1 receptors to help the immune system fight tumors. Available as a 1200 mg/20 mL solution in single-usUpdated 03/24/2026
- InebilizumabState of VirginiaUPLIZNA (inebilizumab) is a prescription monoclonal antibody that targets CD19 on immune cells. It's administered intravenously for certain autoimmune conditions. Manufactured by Viela Bio and Horizon Therapeutics, it's available as a 10 mg/mL solution in singUpdated 03/24/2026
Where this catalog comes from
- Data.gov CatalogU.S. General Services Administration
- State and local open data portalsSocrata Discovery API
- State and city CKAN portalsCalifornia, Virginia, Boston, Houston and more
- Government ArcGIS Hub sitesCity and county GIS data
Catalog checked 10/24/2026
We list dataset descriptions only. Downloads and APIs link straight to the official government source, which holds the current version and its terms of use.
Source: Data.gov · Last updated 10/24/2026 · Listing only; the data stays with the publisher
Share: